Symbols / SENS $6.69 -3.04% Senseonics Holdings, Inc. Common Stock

Healthcare • Medical Devices • United States • NMS
SENS Chart
About

Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. Its products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Medical Devices Market Cap 279.44M
Enterprise Value 235.56M Income -69.11M Sales 35.26M
Book/sh 1.48 Cash/sh 2.25 Dividend Yield —
Payout 0.00% Employees 130 IPO —
P/E — Forward P/E -2.54 PEG —
P/S 7.93 P/B 4.52 P/C —
EV/EBITDA -3.52 EV/Sales 6.68 Quick Ratio 4.37
Current Ratio 4.83 Debt/Eq 67.77 LT Debt/Eq —
EPS (ttm) -1.66 EPS next Y -2.63 EPS Growth —
Revenue Growth 71.80% Earnings 2026-05-07 ROA -37.68%
ROE -168.27% ROIC — Gross Margin 44.71%
Oper. Margin -146.78% Profit Margin -196.03% Shs Outstand 41.77M
Shs Float 37.86M Short Float 11.91% Short Ratio 9.26
Short Interest — 52W High 15.74 52W Low 5.25
Beta 1.05 Avg Volume 487.10K Volume 208.05K
Target Price $18.92 Recom None Prev Close $6.90
Price $6.69 Change -3.04%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$18.92
Mean price target
2. Current target
$6.69
Latest analyst target
3. DCF / Fair value
$-20.04
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$6.69
Low
$9.00
High
$31.00
Mean
$18.92

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2025-11-06 main HC Wainwright & Co. Buy → Buy $19
2025-11-05 main TD Cowen Buy → Buy $15
2025-11-05 main Barclays Overweight → Overweight $31
2025-08-27 init Barclays — → Overweight $2
2025-07-15 init TD Cowen — → Buy $1
2025-07-08 main HC Wainwright & Co. Buy → Buy $1
2025-04-10 init Mizuho — → Outperform $2
2025-03-05 reit HC Wainwright & Co. Buy → Buy $2
2024-11-15 reit HC Wainwright & Co. Buy → Buy $2
2024-08-14 reit HC Wainwright & Co. Buy → Buy $2
2024-03-11 reit HC Wainwright & Co. Buy → Buy $2
2023-11-14 reit HC Wainwright & Co. Buy → Buy $2
2023-08-15 main HC Wainwright & Co. Buy → Buy $2
2023-07-19 init Jefferies — → Underperform $1
2023-05-11 reit HC Wainwright & Co. Buy → Buy $3
2022-07-25 main HC Wainwright & Co. — → Buy $3
2021-08-19 init HC Wainwright & Co. — → Buy $6
2021-04-01 down SVB Leerink Outperform → Market Perform $3
2021-03-05 down Raymond James Market Perform → Underperform —
2021-03-05 main SVB Leerink — → Outperform $3
News
RSS: Latest SENS news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-13 GOODNOW TIMOTHY TODD Chief Executive Officer — 17,225 $5.79 $99,733
2026-03-13 ROEDER DOUGLAS A Director — 17,500 $5.73 $100,275
2026-01-02 STEVEN EDELMAN VICTOR Director — 2,185 $5.89 $12,870
2026-01-02 FIORENTINO EDWARD J Director — 2,398 $5.89 $14,124
2026-01-02 ROEDER DOUGLAS A Director — 2,504 $5.89 $14,749
2026-01-02 PRINCE DOUGLAS S Director — 1,379 $5.89 $8,122
2025-11-10 STEVEN EDELMAN VICTOR Director — 10,000 $6.55 $65,500
2025-11-07 GOODNOW TIMOTHY TODD Chief Executive Officer — 17,210 $5.87 $101,023
2025-11-07 ROEDER DOUGLAS A Director — 15,000 $5.83 $87,450
2025-11-07 SULLIVAN FREDERICK T Chief Financial Officer — 5,415 $5.88 $31,840
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
35.26
+56.89%
22.47
+0.37%
22.39
+36.62%
16.39
Operating Revenue
35.26
+56.89%
22.47
+0.37%
22.39
+36.62%
16.39
Cost Of Revenue
19.49
-11.14%
21.94
+13.68%
19.30
+41.25%
13.66
Reconciled Cost Of Revenue
19.49
-11.14%
21.94
+13.68%
19.30
+41.25%
13.66
Gross Profit
15.76
+2857.41%
0.53
-82.76%
3.09
+13.39%
2.73
Operating Expense
84.10
+11.58%
75.38
-4.22%
78.69
+10.29%
71.35
Research And Development
31.59
-23.22%
41.14
-15.61%
48.75
+22.74%
39.72
Selling General And Administration
52.51
+53.39%
34.23
+14.32%
29.94
-5.35%
31.63
Selling And Marketing Expense
—
—
—
—
General And Administrative Expense
—
—
—
—
Other Gand A
—
—
—
—
Total Expenses
103.59
+6.45%
97.31
-0.69%
97.99
+15.26%
85.02
Operating Income
-68.34
+8.69%
-74.84
+1.01%
-75.60
-10.17%
-68.63
Total Operating Income As Reported
-68.34
+8.69%
-74.84
+1.01%
-75.60
-10.17%
-68.63
EBITDA
-62.65
+8.81%
-68.70
-43.12%
-48.01
-129.67%
161.81
Normalized EBITDA
-62.65
+8.95%
-68.81
-0.06%
-68.76
-4.31%
-65.92
Reconciled Depreciation
1.51
+2.51%
1.48
+15.51%
1.28
+29.64%
0.98
EBIT
-64.16
+8.57%
-70.18
-42.40%
-49.28
-130.64%
160.82
Total Unusual Items
—
0.10
-99.51%
20.76
-90.89%
227.73
Total Unusual Items Excluding Goodwill
—
0.10
-99.51%
20.76
-90.89%
227.73
Special Income Charges
—
—
0.00
+100.00%
-0.24
Other Special Charges
—
—
—
0.10
Write Off
—
—
0.00
-100.00%
0.14
Net Income
-69.11
+12.09%
-78.62
-30.18%
-60.39
-142.49%
142.12
Pretax Income
-69.11
+12.09%
-78.62
-30.18%
-60.39
-142.49%
142.12
Net Non Operating Interest Income Expense
-0.75
+80.86%
-3.94
+31.54%
-5.75
+65.95%
-16.88
Interest Expense Non Operating
4.95
-41.32%
8.44
-24.06%
11.11
-40.60%
18.70
Net Interest Income
-0.75
+80.86%
-3.94
+31.54%
-5.75
+65.95%
-16.88
Interest Expense
4.95
-41.32%
8.44
-24.06%
11.11
-40.60%
18.70
Interest Income Non Operating
4.20
-6.75%
4.50
-16.04%
5.36
+193.97%
1.82
Interest Income
4.20
-6.75%
4.50
-16.04%
5.36
+193.97%
1.82
Other Income Expense
-0.02
-114.29%
0.16
-99.23%
20.96
-90.79%
227.62
Other Non Operating Income Expenses
-0.02
-138.98%
0.06
-70.79%
0.20
+298.04%
-0.10
Gain On Sale Of Security
—
0.10
-99.51%
20.76
-90.89%
227.97
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-69.11
+12.09%
-78.62
-30.18%
-60.39
-142.49%
142.12
Net Income From Continuing Operation Net Minority Interest
-69.11
+12.09%
-78.62
-30.18%
-60.39
-142.49%
142.12
Net Income From Continuing And Discontinued Operation
-69.11
+12.09%
-78.62
-30.18%
-60.39
-142.49%
142.12
Net Income Continuous Operations
-69.11
+12.09%
-78.62
-30.18%
-60.39
-142.49%
142.12
Normalized Income
-69.11
+12.20%
-78.72
+3.00%
-81.15
+5.21%
-85.61
Net Income Common Stockholders
-69.11
+12.09%
-78.62
-30.18%
-60.39
-142.49%
142.12
Diluted EPS
—
-2.50
-2172.73%
-0.11
+0.00%
-0.11
Basic EPS
—
-2.50
-2172.73%
-0.11
-136.67%
0.30
Basic Average Shares
—
629.72
+10.87%
567.97
+21.37%
467.95
Diluted Average Shares
—
629.72
+10.87%
567.97
-8.13%
618.21
Diluted NI Availto Com Stockholders
-69.11
+12.09%
-78.62
-30.18%
-60.39
+10.06%
-67.15
Average Dilution Earnings
—
—
0.00
+100.00%
-209.27
Line Item Trend 2023-12-31
Total Assets
138.22
Current Assets
130.03
Cash Cash Equivalents And Short Term Investments
109.46
Cash And Cash Equivalents
75.71
Cash Equivalents
72.95
Cash Financial
2.76
Other Short Term Investments
33.75
Receivables
6.60
Accounts Receivable
4.53
Gross Accounts Receivable
4.53
Taxes Receivable
1.79
Accrued Interest Receivable
0.27
Inventory
8.78
Raw Materials
1.28
Work In Process
5.33
Finished Goods
2.16
Prepaid Assets
5.20
Restricted Cash
0.00
Other Current Assets
0.00
Total Non Current Assets
8.19
Net PPE
1.18
Gross PPE
3.67
Accumulated Depreciation
-2.48
Properties
0.00
Machinery Furniture Equipment
3.14
Other Properties
—
Leases
0.53
Goodwill And Other Intangible Assets
0.00
Other Intangible Assets
—
Investments And Advances
0.00
Non Current Prepaid Assets
—
Other Non Current Assets
7.01
Total Liabilities Net Minority Interest
102.42
Current Liabilities
17.26
Payables And Accrued Expenses
11.55
Payables
4.57
Accounts Payable
4.57
Current Accrued Expenses
6.98
Pensionand Other Post Retirement Benefit Plans Current
4.80
Current Debt And Capital Lease Obligation
0.37
Current Debt
—
Other Current Borrowings
—
Current Capital Lease Obligation
0.37
Other Current Liabilities
0.03
Total Non Current Liabilities Net Minority Interest
85.17
Long Term Debt And Capital Lease Obligation
47.41
Long Term Debt
41.20
Long Term Capital Lease Obligation
6.21
Other Non Current Liabilities
—
Preferred Securities Outside Stock Equity
37.66
Stockholders Equity
35.80
Common Stock Equity
35.80
Capital Stock
0.53
Common Stock
0.53
Share Issued
530.36
Ordinary Shares Number
530.36
Treasury Shares Number
0.00
Additional Paid In Capital
904.53
Retained Earnings
-869.26
Gains Losses Not Affecting Retained Earnings
-0.01
Other Equity Adjustments
-0.01
Total Equity Gross Minority Interest
35.80
Total Capitalization
76.99
Working Capital
112.77
Invested Capital
76.99
Total Debt
47.78
Net Debt
—
Capital Lease Obligations
6.58
Net Tangible Assets
35.80
Tangible Book Value
35.80
Current Notes Payable
0.00
Current Provisions
0.51
Derivative Product Liabilities
0.10
Duefrom Related Parties Current
—
Financial Assets
—
Interest Payable
0.70
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-59.13
+2.21%
-60.47
+13.82%
-70.16
-5.81%
-66.31
Cash Flow From Continuing Operating Activities
-59.13
+2.21%
-60.47
+13.82%
-70.16
-5.81%
-66.31
Net Income From Continuing Operations
-69.11
+12.09%
-78.62
-30.18%
-60.39
-142.49%
142.12
Depreciation Amortization Depletion
1.51
+2.51%
1.48
+15.51%
1.28
+29.64%
0.98
Depreciation
—
1.48
+15.51%
1.28
+29.64%
0.98
Depreciation And Amortization
1.51
+2.51%
1.48
+15.51%
1.28
+29.64%
0.98
Other Non Cash Items
2.32
-42.83%
4.07
-45.73%
7.49
-38.42%
12.16
Stock Based Compensation
10.15
+10.06%
9.22
+6.36%
8.67
+0.64%
8.62
Provisionand Write Offof Assets
0.69
-82.39%
3.94
+2165.52%
0.17
0.00
Asset Impairment Charge
—
—
0.00
-100.00%
0.14
Operating Gains Losses
—
-0.10
+99.51%
-20.75
+90.89%
-227.87
Gain Loss On Investment Securities
—
-0.10
+98.47%
-6.65
+97.08%
-227.87
Net Foreign Currency Exchange Gain Loss
—
0.00
+100.00%
-14.11
0.00
Change In Working Capital
-3.28
-478.96%
0.86
+121.81%
-3.97
-60.50%
-2.47
Change In Receivables
-6.76
-150.65%
-2.70
-23.19%
-2.19
-358.37%
-0.48
Changes In Account Receivables
-6.76
-150.65%
-2.70
-23.19%
-2.19
-358.37%
-0.48
Change In Inventory
-2.98
-527.44%
0.70
+142.34%
-1.64
-66.23%
-0.99
Change In Prepaid Assets
1.47
-49.47%
2.90
+1151.09%
-0.28
+66.71%
-0.83
Change In Payables And Accrued Expense
5.93
+575.20%
0.88
-30.62%
1.27
+117.70%
0.58
Change In Accrued Expense
4.72
+74.25%
2.71
+362.82%
-1.03
-175.35%
1.37
Change In Payable
1.22
+166.63%
-1.83
-179.58%
2.30
+392.61%
-0.79
Change In Account Payable
1.22
+166.63%
-1.83
-179.58%
2.30
+392.61%
-0.79
Change In Other Current Liabilities
-0.94
-2.96%
-0.91
+18.72%
-1.12
-48.22%
-0.76
Investing Cash Flow
-53.42
-262.68%
32.84
-63.40%
89.71
+233.73%
26.88
Cash Flow From Continuing Investing Activities
-53.42
-262.68%
32.84
-63.40%
89.71
+233.73%
26.88
Capital Expenditure
-1.12
+50.16%
-2.24
-539.71%
-0.35
-12.18%
-0.31
Capital Expenditure Reported
-1.12
+50.16%
-2.24
-539.71%
-0.35
-12.18%
-0.31
Net Investment Purchase And Sale
-52.31
-249.12%
35.08
-61.05%
90.06
+231.19%
27.19
Purchase Of Investment
-100.69
-73.55%
-58.02
+15.35%
-68.54
+34.54%
-104.71
Sale Of Investment
48.39
-48.02%
93.09
-41.30%
158.60
+20.24%
131.90
Financing Cash Flow
78.19
+191.42%
26.83
+31.74%
20.37
-51.23%
41.76
Cash Flow From Continuing Financing Activities
78.19
+191.42%
26.83
+31.74%
20.37
-51.23%
41.76
Net Issuance Payments Of Debt
-20.40
-305.02%
9.95
+698.56%
1.25
+142.58%
-2.93
Issuance Of Debt
0.00
-100.00%
9.95
-59.30%
24.45
0.00
Repayment Of Debt
-20.40
0.00
+100.00%
-23.20
-692.89%
-2.93
Long Term Debt Issuance
0.00
-100.00%
9.95
-59.30%
24.45
0.00
Long Term Debt Payments
-20.40
0.00
+100.00%
-23.20
-692.89%
-2.93
Net Long Term Debt Issuance
-20.40
-305.02%
9.95
+698.56%
1.25
+142.58%
-2.93
Net Common Stock Issuance
100.59
+447.76%
18.36
+148.97%
7.38
-78.42%
34.17
Proceeds From Stock Option Exercised
0.14
-20.11%
0.18
-98.79%
14.77
+1262.64%
1.08
Net Other Financing Charges
-2.15
-29.10%
-1.66
+45.06%
-3.03
-17.78%
-2.57
Changes In Cash
-34.36
-4211.54%
-0.80
-102.00%
39.92
+1611.66%
2.33
Beginning Cash Position
74.91
-1.05%
75.71
+111.52%
35.79
+6.97%
33.46
End Cash Position
40.55
-45.87%
74.91
-1.05%
75.71
+111.52%
35.79
Free Cash Flow
-60.24
+3.92%
-62.70
+11.07%
-70.51
-5.84%
-66.62
Interest Paid Supplemental Data
4.05
-10.14%
4.51
+22.51%
3.68
-44.00%
6.57
Amortization Of Securities
-1.42
-7.73%
-1.32
+50.56%
-2.67
—
Change In Interest Payable
-0.49
-669.77%
0.09
+177.42%
0.03
+132.63%
-0.10
Common Stock Issuance
100.59
+447.76%
18.36
+148.97%
7.38
-78.42%
34.17
Issuance Of Capital Stock
100.59
+447.76%
18.36
+148.97%
7.38
-84.03%
46.17
Net Preferred Stock Issuance
—
—
0.00
-100.00%
12.00
Preferred Stock Issuance
—
—
0.00
-100.00%
12.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category